OverviewChartProfileKey statisticsFinancialsTechnicalNewsTraderScreen

Prothena Corporation PLC/  IE00B91XRN20  /

NASDAQ
8/30/2024  10:00:00 PM Chg. +0.7100 Volume Bid12:55:48 AM Ask12:55:48 AM Market Capitalization Dividend Y. P/E Ratio
22.2700USD +3.29% 300,305
Turnover: 4.66 mill.		 21.5000Bid Size: 100 23.8800Ask Size: 100 888.91 mill.USD 0.00% -
GlobeNewswire 8/5 ORIC Pharmaceuticals Expands Leadership Team with the Appointment of Keith Lui as Senior Vice Presid...
GlobeNewswire 3/28/2022 Prothena Announces FDA Clearance of IND for PRX012, a Subcutaneous Anti-Amyloid Beta Antibody Under ...
GlobeNewswire 3/21/2022 Prothena to Participate in Stifel 2022 Virtual CNS Days
GlobeNewswire 3/16/2022 Prothena Presents New Data for Alzheimer’s and Parkinson’s Disease Programs at AD/PD 2022
GlobeNewswire 2/17/2022 Prothena Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Financial Guidanc...
GlobeNewswire 2/10/2022 Prothena to Report Fourth Quarter and Full Year 2021 Financial Results and Host Webcast Conference C...
GlobeNewswire 11/29/2021 Prothena to Participate in JMP Securities Hematology and Oncology Summit
GlobeNewswire 11/4/2021 Prothena Reports Third Quarter 2021 Financial Results and Business Highlights
GlobeNewswire 10/28/2021 Prothena to Report Third Quarter 2021 Financial Results on November 4th
GlobeNewswire 10/1/2021 Prothena Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 10/1/2021 Prothena Announces Executive Appointments
GlobeNewswire 9/3/2021 Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 9/1/2021 Prothena to Participate in Upcoming September Healthcare Conferences
GlobeNewswire 8/5/2021 Prothena Reports Second Quarter 2021 Financial Results and Business Highlights
GlobeNewswire 7/29/2021 Prothena to Report Second Quarter 2021 Financial Results on August 5th
GlobeNewswire 7/26/2021 Prothena Presents New Data from Robust Alzheimer’s Portfolio at the Alzheimer’s Association Internat...
GlobeNewswire 7/20/2021 Prothena to Present Data from Two of its Alzheimer’s Disease Programs at the Alzheimer’s Association...
TeleTrader 7/12/2021 Novo Nordisk buys Prothena's heart therapy drug
GlobeNewswire 7/12/2021 Prothena and Novo Nordisk Announce Acquisition Agreement for Prothena’s ATTR Amyloidosis Programme
GlobeNewswire 6/24/2021 Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau PRX005 as the First Program from Global N...
GlobeNewswire 6/10/2021 Prothena to Participate in JMP Securities Life Sciences Conference on June 16
GlobeNewswire 5/20/2021 Prothena Announces Appointment of Sanjiv Patel, MBBS, to its Board of Directors
GlobeNewswire 5/11/2021 Prothena Reports First Quarter 2021 Financial Results and Provides Updated Financial Guidance and R&...
GlobeNewswire 5/10/2021 Prothena Announces Achievement of $60 Million Milestone From Roche for First Patient Dosed in Phase ...
GlobeNewswire 5/7/2021 Prothena Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)